Trial Profile
Effects of menatetrenone [vitamin K2] on bone-loss rates in Norwegian postmenopausal women.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2011
Price :
$35
*
At a glance
- Drugs Menatetrenone (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 09 Feb 2011 New trial record